Parkinson'
Conditions
Interventions
fursultiamine 100mg
Sponsors
Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients hereditary neurological or neurodegenerative disease who agreed to participate in this study
Exclusion criteria
Exclusion criteria: Patients disagreed to this study Who have been regarded to be inappropriate to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| UPDRS, SARA, FSS, PFSI(before treatment and at 1, 3, 6 and 12 months after treatment) | — |
Countries
Japan
Contacts
Public ContactNoriyuki Miyaue
Ehime University Graduate School of Medicine Department of Neurology and Clinical Pharmacology
Outcome results
None listed